Linezolid for Syphilis Pilot Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Howard Brown Health
Chicago, Illinois, United States
- Open Arms Healthcare Center
Jackson, Mississippi, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Wake Forest Baptist Health
Greensboro, North Carolina, United States
- Open Door Health
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Sept 2023
- Primary completion
- 31 Aug 2026
- Completion
- 31 Aug 2026
- Last update posted
- 12 Mar 2026
- Registered enrollment
- 24
- Registry id
- NCT05548426
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.